Driven Brands exited its Q4 earnings week with the Street delivering a clear verdict: targets down, ratings mostly held, and the stock absorbing a fresh 7% single-session hit on May 19 after guidance disappointed.
The analyst response to Tuesday's print was swift and uniform. Four firms moved targets lower on May 20 alone. Morgan Stanley trimmed to $16 from $17 while staying Equal-Weight. RBC Capital cut to $18 from $20, keeping its Outperform. BTIG dropped to $17 from $21, maintaining Buy. Piper Sandler moved the other direction on the target — up to $13 from $11 — but remained Neutral, the lone note of contrarianism in an otherwise cautious morning. The mean target now sits at $17.91 against a close of $13.23, implying roughly 35% upside on paper, but that gap reflects the Street's uncertainty more than conviction: bulls keep ratings but keep cutting numbers. The analyst rec differential factor score ranks in the 93rd percentile of the universe, flagging the wide gap between current ratings and where analysts actually have targets relative to price.
The bull and bear cases are clearly drawn. Bears point to the FY25 same-store sales forecast coming in below the bottom of the prior 1%–3% guidance range and adjusted EBITDA estimates slashed from $531M to $451M. The Franchise Brands segment revenue shortfall is the sharpest pain point. The EV transition and a potential drift toward DIY maintenance are structural overhangs. Bulls counter with Take 5's unit economics — all 2023 cohorts hitting $1M average unit volume within 24 months — and attach rates climbing from the mid-to-high 40s into the low 50s. With the PE multiple running near 10x and EV/EBITDA at roughly 12.4x, valuation has compressed sharply from where it was a month ago, when both multiples were meaningfully higher.
The positioning picture is less alarming than the guidance story might suggest. Short interest runs at 7.8% of the free float — elevated, but down about 2% on the week and only marginally higher than a month ago. The short score has eased from 69.9 at the start of the week to 64.8, consistent with some short covering rather than fresh pile-in following the earnings drop. Borrowing costs are negligible at 0.54% and have barely moved in 30 days. Availability has loosened sharply to 338% — meaning there are more than three shares available to borrow for every one currently lent out — well above the 52-week low of 135.5%. That's not a borrow-constrained setup. Options positioning reinforces the picture: the put/call ratio hit 0.0085 on May 19, the lowest reading of the past 52 weeks and well below its 20-day average of 0.052. That's not a crowded short or a panicked options market — it's a stock that got hit on guidance but where speculative bearish positioning remains measured.
Institutional flows add a secondary thread worth watching. ADW Capital Management and Rubric Capital Management each entered the register in Q1, both reporting fresh 4M and 3M share positions respectively as of March 31. FMR added 2.76M shares in the same quarter. Roark Capital still controls 61.8% of the company — a structural overhang that limits float — but the Q1 pattern of active managers initiating and adding suggests some buyers were building into the weakness that preceded the earnings print.
The insider activity since February has been exclusively sells, mostly small tax-related disposals at significance scores of 1, with the CFO and several EVPs all transacting at prices between $10.34 and $13.41. None of the trades were material in size, but the directional consistency — no purchases across the C-suite since at least late 2025 — is worth noting as the stock hovers near its recent lows.
The next signal to track is whether the Street's target cuts have stabilised or whether further reductions follow as analysts work through the FY26 guide in detail. The distance between the $13.23 close and the $17.91 mean target will narrow not through price alone.
See the live data behind this article on ORTEX.
Open DRVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
